Request appointment
1515 Holcombe BlvdHouston, TX 77030
Overview of Dr. Nusrat
Dr. Maliha Nusrat is an oncologist in Houston, TX and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Sloan Kettering Bergen. She received her medical degree from Aga Khan Medical College and has been in practice 17 years. She is one of 529 doctors at Memorial Sloan Kettering Cancer Center and one of 19 doctors at Memorial Sloan Kettering Bergen who specialize in Oncology. She has more than 20 publications and over 250 citings.
Education & Training
MD Anderson UTHealth Graduate School of Biomedical SciencesMS, Cancer Biology/ Biomedical Sciences, 2020
University of Texas M D Anderson Cancer CenterFellowship, Investigational Cancer Therapeutics Fellowship In Early Drug Development, 2018 - 2019
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2015 - 2018- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2012 - 2015
Aga Khan Medical CollegeClass of 2009
Certifications & Licensure
NY State Medical License 2019 - 2028
TX State Medical License 2026 - 2028
NJ State Medical License 2019 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
American Board of Medical QualityCertified in Medical Quality
Clinical Trials
- Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Maintenance Treatment (Trastuzumab and Pertuzumab) After Initial Chemotherapy in a Phase Ib/II Trial for Advanced HER2 Positive Breast Cancer Start of enrollment: 2021 May 20
- Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN Start of enrollment: 2020 Jul 17
Publications & Presentations
PubMed
- Molecular Lineages of Sporadic Mismatch Repair-Deficient Colorectal Cancer.Michael B Foote, Guilherme Harada, Somer Abdelfattah, Nil Urganci, Paolo Manca
Clinical Cancer Research. 2026-07-17 - Trifluridine-Tipiracil with and without Bevacizumab in Colorectal Cancer.Maliha Nusrat, Ruizhi Zhao, Nadeem Khan, Yuexi Wang, Kathryn L Penney
NEJM Evidence. 2026-03-01 - Quantifying the risk of sexual dysfunction in men treated with pelvic radiation therapy for locally advanced rectal cancer.Kush H Patel, Neal Kim, Kathryn R Tringale, Lily Boe, Marsha Reyngold
Frontiers in Oncology. 2026-01-01
Press Mentions
Oncology Breakthroughs Could Impact DentistryApril 24th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
